Yingying Yang

The Pharmacokinetics and Bioequivalence of Desvenlafaxine Succinate in Chinese Healthy Subjects Under Fasting and Fed States.

Wei Hu, Yue Wang, Xueyuan Zhang, 2023, Clinical pharmacology in drug development.

Iruplinalkib (WX‑0593), a novel ALK/ROS1 inhibitor, overcomes crizotinib resistance in preclinical models for non-small cell lung cancer

Xinmei Wang, Qingmei Zheng, Shuyong Zhao, 2023, Investigational New Drugs.

Standard: Human intestinal organoids

B. Zhao, Liu Wang, Zhijian Sun, 2023, Cell Regeneration.